Références
Peyrin-Biroulet L, Ferrante M, Magro F, Campbell S, Franchimont D, Fidder H, et al. Results from the 2nd Scientific Workshop of the ECCO (I): impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5:477–83.
Pineton de Chambrun G, Peyrin-Biroulet L, Lemann M, Colombel JF. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol 2010;7:15–29.
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–9.
Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID). Gut 1989;30: 983–9.
Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 2013;145:987–95.
Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990;99:956–63.
Author information
Authors and Affiliations
Corresponding author
Additional information
Cet article a déjà été publié sous la référence: Peyrin-Biroulet L. Post’U FMC-HGE 2014:267–8
About this article
Cite this article
Peyrin-Biroulet, L. Scores endoscopiques des maladies inflammatoires chroniques de l’intestin. Acta Endosc 44, 408–409 (2014). https://doi.org/10.1007/s10190-014-0403-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-014-0403-z